Skip to content

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients: a Stepped Wedge Cluster Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05443737
Enrollment
2800
Registered
2022-07-05
Start date
2022-01-01
Completion date
2027-08-31
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Fertility Preservation

Keywords

Oncofertility, Fertility preservation, Adolescent and young adult cancer

Brief summary

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with observing and gathering information on how the intervention is implemented. The investigators hypothesize that implementation of the intervention will result in increased young cancer survivors' engagement in goal-concordant oncofertility care.

Interventions

The multi-component oncofertility care intervention includes: (1) an adaptive and smart default electronic health record-based oncofertility needs screen and referral pathway, (2) telehealth oncofertility counseling as indicated, and (3) telehealth oncofertility financial navigation as indicated.

Sponsors

Rady Children's Hospital, San Diego
CollaboratorOTHER
City of Hope Medical Center
CollaboratorOTHER
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Masking description

Fertility specialists and their support staff will be blinded to the intervention status of the cluster from which a patient is referred to minimize differences in counseling in patients whom they expect to receive financial navigation.

Intervention model description

Stepped wedge cluster randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
0 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed cancer or cancer relapse * Primary language English or Spanish * Receiving oncology care at participating clinical sites * Ages 0 to 42 years if female * Ages 0 to 50 years if male

Exclusion criteria

* Non-melanoma skin cancer, because primary treatment is excision with no infertility risk * Metastatic/Stage IV non-thyroid solid tumors, because of poor prognosis

Design outcomes

Primary

MeasureTime frameDescription
Number of reproductive-aged female and male patients (aged 12 to 39 years) who engage in goal-concordant oncofertility care12 weeks after oncology visitThe proportion of eligible reproductive-aged male and female patients (aged 12 to 39 years) who engage in oncofertility services (1\| an oncofertility needs screen, 2\| referral to oncofertility consult, 3\| oncofertility consult, and/or 4\| fertility preservation services) that meet the patient's individual needs will be abstracted from medical records using standardized case report forms.
Decisional Conflict12 weeks after oncology visitThe 16-item Decisional Conflict Scale (DCS) will be used to measure patients' decisional conflict for engaging in fertility preservation services. The DCS consists of 16 statements with 5 response options (ranging from strongly agree to strongly disagree) that measures the patient's perceptions of uncertainty in choosing options, feeling informed, values clarity, support in decision making, and effective decision making. The DCS total score will be dichotomized at 37.5 (scale 0-100; \> 37.5 indicates high decisional conflict).

Secondary

MeasureTime frameDescription
Number of female (aged 0 to 42 years) and male (aged 0 to 50 years) patients who engage in goal-concordant oncofertility care12 weeks after oncology visitThe proportion of eligible female and male patients (aged 0 to 42 years for females; 0 to 50 years for males) who engage in oncofertility services \[1) an oncofertility needs screen, 2) referral to oncofertility consult, 3) oncofertility consult, and/or 4) fertility preservation services\] that meet the patient's individual needs will be abstracted from medical records using standardized case report forms.
Number of female patients (aged 0 to 42 years) who engage in goal-concordant oncofertility care12 weeks after oncology visitThe proportion of eligible female patients (aged 0 to 42 years) who engage in oncofertility services \[1) an oncofertility needs screen, 2) referral to oncofertility consult, 3) oncofertility consult, and/or 4) fertility preservation services\] that meet the patient's individual needs will be abstracted from medical records using standardized case report forms.
Number of male patients (aged 0 to 50 years) who engage in goal-concordant oncofertility care12 weeks after oncology visitThe proportion of eligible male patients (aged 0 to 50 years) who engage in oncofertility services \[1) an oncofertility needs screen, 2) referral to oncofertility consult, 3) oncofertility consult, and/or 4) fertility preservation services\] that meet the patient's individual needs will be abstracted from medical records using standardized case report forms.

Countries

United States

Contacts

Primary ContactH. Irene Su, MD, MSCE
hisu@health.ucsd.edu858-822-5986
Backup ContactSally AD Romero, PhD, MPH
saromero@health.ucsd.edu858-822-1371

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026